A B S T R A C T Events that lead to phagocytosis of complement (C3)-or
INTRODUCTION
Surface membrane receptors for two fragments (C3b and C3bi; [1] [2] [3] [4] of the third component of complement (C3) and for the Fc region of IgG (5, 6) are present on phagocytic cells. Interactions between these receptors and their respective ligands lead to a number of important biologic functions such as immune adherence, phagocytosis, antibody-dependent cellular cytotoxicity, and histaminase and lysosomal enzyme release (1, (7) (8) (9) (10) . The mechanisms involved in coupling receptor ligand interactions with these various functions are poorly understood. The development of the monoclonal antibody technique by Kohler and Milstein (11) offers means of analyzing such complex interactions rigorously. Monoclonal antibodies to the C3b and Fc receptors have proved useful in elucidating the structure and function of these molecules (12, 13) .
Monoclonal antibodies to other cell surface antigens were instrumental in defining specific surface markers and have been extensively used for cell phenotyping and in studies of cell differentiation. Most of these antibodies, however, are directed against antigens for which function has not been defined. Among these monoclonals are antibodies against a monocyte-granulocyte surface antigen named Mol, which consists of two distinct noncovalently linked glycoproteins with molecular weights of 155,000 and 94,000, as evidenced by sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis (PAGE)' of antibody immunoprecipitates from monocytes under both reducing or nonreducing conditions (14) .
We now report that two monoclonal antibodies (an IgM and an IgG2a) to Mol specifically inhibited binding of C3bi-coated sheep erythrocytes (Es) to human neutrophils or monocytes. The Fab fragment of the IgG2a antibody inhibited ingestion by polymorphonuclear leukocyte (PMN) of particles opsonized with C3. Ingestion of particles opsonized with IgG alone was also inhibited. Noncytotoxic release of granulocyte enzymes was inhibited by this Fab fragment when induced by C3bi-coated zymosan but not by phorbol myristate acetate (PMA). This antibody is directed against the 155,000-dalton fragment of the Mol antigen complex, as determined by the immunoblotting technique (15) .
METHODS
Phagocytes, lymphocytes, and tumor cell lines. Human neutrophils were isolated from venous blood by density gradient centrifugation on Ficoll-Hypaque, followed by hypotonic lysis of the pellet, as previously described (16) . Monocytes were purified by incubating the mononuclear cell fraction (obtained from Ficoll-Hypaque centrifugation) on plastic petri dishes (17) . B lymphocytes were purified from mononuclear cell fractions as previously described (17) . 55% of the lymphocyte population had the Bi antigen (a surface antigen specific for B lymphocytes (18) . Human erythrocytes from random donors were washed six times in phosphatebuffered saline (PBS) containing 10 mM EDTA.
Human B lymphoblastoid cell line (Raji) and CEM T lymphoblastoid cell line were provided by Dr Immunoglobulins and complement proteins. IgG rabbit antibody to Es was bought from Cordis Laboratories, Miami, FL. IgM rabbit antiserum to Es was obtained by immunizing rabbits with Es stroma as described (19 (17) . The Fab fragments of monoclonal antibodies were prepared as described (20) and purity of fragments shown by SDS PAGE analysis. Human C3, C3b dimers, ,BIH, and C3b inactivator were purified as described (2, (21) (22) . CS was further purified by sequential affinity chromatography on Sepharose to which the Ig fraction of rabbit antibodies to human C5, 1 Abbreviations used in this paper: Es, sheep erythrocyte; HSA, human serum albumin; ORO, oil red 0; PAGE, polyacrylamide gel electrophoresis; RT, room temperature.
,BIH, and IgG were previously linked with cyanogen bromide (2) .
Iodinations. Monoclonal Fab fragments or rabbit IgG antimouse immunoglobulins were radiolabeled with 125I (New England Nuclear, Boston, MA), using chloramine T (10-15:1 molar ratio) to a specific activity of 100,000 and 4 X 106 cpm/,ug, respectively (23) . Fluid phase C3b dimers were iodinated with insolubilized lactoperoxidase and glucoseoxidase (enzymobeads, Bio-Rad Chemicals, Richmond, VA) as described (2) .
Preparation of immunoglobulin and complement-coated particles. Es were coated with a rabbit IgG antibody to Es by incubating Es with the antibody in various dilutions (1:300 to 1:1,200) in PBS for 15 minutes at 37°C, followed by several washes in the same buffer.
Es coated with C3b (EAC43b) were made as follows: Es were sensitized with rabbit IgM anti-Forssman antibody, guinea pig Cl, human C4, guinea pig C2, and limited amounts of human C3 as described by Rapp and Borsos (19 (1 mg) and TPCK trypsin were added (0.6% wt/wt) in a total vol of 0.5 ml PBS for 6 min at RT. Further C3b was deposited by using the nickel-stabilized C3 convertase, as described (27) . C3bi-coated zymosan (ZC3bi) was made by incubating ZC3b in 1 ml of normal human plasma (extensively preabsorbed with washed zymosan) for 16 h at 37°C. This resulted in >90% release of C3c antigen after trypsin treatment of washed particles, indicating the presence of the C3bi fragment. This prolonged incubation was necessary, because of the relative insensitivity of C3b deposited on zymosan to C3b inactivator cleavage (28) .
Opsonized oil red 0 (ORO) and ORO coated with tetanus toxoid (Massachusetts Public Health Biologic Lab.) and human antitetanus toxoid immune globulin (Lederle Laboratories, Pearl River, NY) were prepared exactly as described (7, 29) . Opsonized (C3 coated) ORO particles were used immediately or frozen at -90°C and used within 3 wk.
Rosette formation. 25 Ml of human leukocytes (PMN, monocytes, Raji cells, or B lymphocytes) at 4 X 106/ml in 0.025 M veronal buffer, containing 3.2% dextrose, 1% human serum albumin, 0.2% sodium azide, and 1 mg/ml soybean trypsin inhibitor (Millipore Corp.) were incubated with serial dilutions of immune or nonimmune ascites (or purified monoclonal anti-Mol and control antibodies) for 20 min at RT. 25 Al of indicator cells (2 X 108/ml) were added and the mixture incubated at 37°C for 30 min. To assess rosette formation, the cell mixture was gently resuspended and a drop placed on a hemocytometer; 400 human cells were then examined. Binding of three or more Es to a leukocyte was considered a rosette. '251-C3b dimer binding to human erythrocytes was carried out as described (2) .
Assays of phagocytosis. Ingestion of opsonized or IgGcoated ORO particles was performed as follows: Phagocytes (8 X at 37°C before mixing. Afterward, the reaction mixture was incubated at 37°C for 5 min with continuous agitation. The reaction was stopped by adding 1 ml of PBS containing 1 mM N-ethyl maleimide to each tube, followed by two washes. The rate of ingestion was quantitated as described (7).
Ingestion of Es IgG by PMN preincubated with the Fab fragment of anti-Mol (5 Ag/106 cells) or control antibodies was performed in suspension as described (29) . Quantitation of phagocytosis was done by counting 200 Wright stained PMN under light microscopy. The percentage of cells ingesting one or more erythrocytes was determined. Alternatively, erythrophagocytosis was quantitated using 5"Chromium-labeled Es (17) sensitized with IgG.
Degranulation. Enzyme release from PMN in response to zymosan coated with C3bi was measured as described by Zeiger et al. (30) . Briefly, 100 Ml PMN at a concentration of 5 X 106/ml in Tris buffer containing 0.1% human serum albumin (HSA), 0.0006 M calcium, and 0.001 M magnesium were incubated at RT with buffer alone or the Fab fragment of monoclonal antibodies to Mol, PLT1 (31), J5 (32), or Mo5 (33) antigens for 25 min. ZC3bi (6 particles/cell), or PMA (1 Mlg/ml) were added to the cells in a total volume of 150 Al and incubated for 30 min at 37°C in a shaking water bath. PMN were then pelleted by centrifugation at 9,000 g for 1 min at 4°C. The supernatant fluid samples as well as supernatant from Triton X-100 solubilized untreated PMN, buffer-treated PMN, and PMN treated with the separate monoclonal antibodies alone were assayed for lysozyme (34) , B-glucuronidase (35) , lactic dehydrogenase (36) , and histaminase (9 Isolation of Mol from '251-labeled PMN with affinity chromatography. PMN were treated with diisopropyl fluorophosphate, surface labeled with iodogen (Pierce Chemical Co., Rockford, IL), and solubilized with Nonidet P-40 (NP-40) as previously described (29) . F(ab')2 anti-Mol antibody was covalently linked to Sepharose CL 6B using cyanogen bromide. 250 MAl of PMN lysate (equivalent to 25 X 107 cells) were preabsorbed with Sepharose (100 Ml of resin) for 2 h at 4°C. The resin was pelleted by centrifugation and the supernatant incubated with 1 ml of anti-Mol Sepharose for 14 h at 4°C. The resin was then poured into a column, washed with 10 vol of PBS containing 2 mM phenyl methyl sulfonyl fluoride and 0.1% NP-40, and eluted with 0.5 N acetic acid containing 0.1% NP-40 (in 1-ml fractions) and the pH was immediately neutralized with 2 M Tris base to pH 7.5. One peak of radioactivity was eluted and analyzed by SDS PAGE (38) . No radioactive peak was obtained with a control Sepharose column to which nonimmune F(ab')2 mouse Ig was covalently linked.
Electrophoretic blotting of PMN membrane proteins followed by immune fixation with monoclonal antibodies. 100-Ml aliquots of PMN lysates were electrophoresed on SDS PAGE, followed by electrophoretic transfer of the proteins to nitrocellulose paper, as described (15) . Immune ascites containing monoclonal antibody to Mol or nonimmune ascites were then incubated with the nitrocellulose strips at appropriate dilutions for 48 h at 37°C. After washing these with buffer, 125I-labeled rabbit IgG to mouse Ig was added and incubated for 1 h at 37°C. Strips were then extensively washed, dried, and exposed to Kodak Industrex C film and developed using a Kodak automated developer (Eastman Kodak Co., Rochester, NY). (Figs. 3 and 4) . Specific release of histaminase, 13-glucuronidase, and lysozyme in the absence of the anti-Mol antibody were 45, 8, and 9%, respectively. No inhibition was seen with control monoclonal antibodies (Fig. 3) . Anti-Mol did not significantly inhibit PMA-induced histaminase, or fB-glucuronidase enzyme release (data not shown).
RESULTS

Inhibition of
Effects on phagocytosis. Fab anti-Mol inhibited serum-opsonized (C3-coated) ORO ingestion by PMN (Fig. 5 A) . Half-maximal inhibition was seen at 8.5 Ag/ml. No inhibition was seen with control Fab antiMo5 antibody. Similarly, the Fab fragment of monoclonal anti-Mol inhibited ingestion of IgG-coated ORO in a dose-dependent manner (Fig. 5 B) . Onehalf-maximal inhibition was seen at an antibody concentration of 6 ,ug/ml. Mouse ascites containing monoclonal anti-Mol or Fab fragment of purified anti-Mol IgG2a specifically inhibited phagocytosis by PMN of Es sensitized with IgG (at subagglutinating doses); (Table II) . Maximal inhibition was seen at 1:100 dilution of immune ascites or 30 usg Fab anti-Mol/ml and ranged between 33 Monoc/ori/AntibodyZgG Fob AddeLd(gJ) FIGURE 3 Effect of Fab anti-Mol (IgG2a) on ZC3bi-induced ,B-glucuronidase release from PMN. 50% inhibition was produced at 10.6 ,g/ml. No method used to quantitate ingestion (Table II) . Higher degrees of inhibition (up to 100%) were obtained with erythrocytes coated with smaller number of IgG molecules (data not shown).
Anti-Mol monoclonal antibody is directed to an epitope present on the 155,000-dalton fragment of the Mol antigen complex. Anti-Mol immunoprecipitated two noncovalently linked membrane glycoproteins from monocytes (14) . Purification of Mol from '251-labeled granulocytes revealed a similar structure (Fig. 6) . To determine against which of the two glycoproteins the anti-Mol antibodies were directed, PMN lysates were first electrophoresed on SDS PAGE, followed by immunoblotting, as described in Methods. As shown in Fig. 6 , only the 155,000-dalton glycoprotein was seen after immunofixation with anti-Mol IgG2a. When purified 1251-Mol was electrophoresed on SDS polyacrylamide gel and then transferred to nitrocellulose, both the 155,000-and 94,000-radiolabeled bands were seen on nitrocellulose paper, as determined by radioautography (data not shown). These data indicate that the epitope recognized by the monoclonal anti-Mol antibody is located on the larger glycoprotein of the Mol complex.
DISCUSSION
Mol antigen is a surface membrane glycoprotein present on granulocytes, monocytes, and null cells and was defined by monoclonal antibodies (17) . The data pre- The 155,000-dalton subunit may function as a lectinlike molecule in promoting contact or adherence between cells and particles whether these were activators or nonactivators of the alternative complement pathway. Interference with this function may inhibit the rate of phagocytosis of C3-or IgG-coated particles. We can not conclusively distinguish among these possibilities at present. The exact functional relationship of the 94,000-dalton glycoprotein that coprecipitates with the 155,000-dalton subunit is also unclear, since both monoclonal antibodies to Mol used in this study recognize an epitope on the 155,000-dalton subunit.
These data establish the functional properties of the 155,000-dalton subunit of Mol antigen. Further studies, however, aimed at isolation of the C3bi receptor by methods dependent on interaction with its ligand and comparison of the molecular species obtained with Mol will be needed before the precise relationship between Mol and specific cell surface receptors can be established.
